Comparing selection on S. aureus between antimicrobial peptides and common antibiotics

Area of Science:

• Microbiology
• Drug Discovery
• Evolutionary Biology

Background:

• The rise of antibiotic resistance necessitates the development of novel therapeutics.
• Antimicrobial peptides (AMPs) are a promising alternative to conventional antibiotics.
• Understanding bacterial resistance evolution to AMPs is crucial for their clinical application.

Purpose of the Study:

• To experimentally compare the evolution of resistance in Staphylococcus aureus to single AMPs, a combination of AMPs, and conventional antibiotics.
• To investigate the fitness costs associated with AMP resistance.
• To evaluate the potential of AMP combinations as a strategy to combat antimicrobial resistance.

Main Methods:

• Bacterial cultures of Staphylococcus aureus were subjected to selection pressure from three distinct AMPs (mammalian, amphibian, insect), an AMP combination, streptomycin, and vancomycin.
• Resistance evolution and associated fitness costs were monitored over time.
• Comparative analysis of resistance development patterns across different selective agents.

Main Results:

• Resistance evolved readily against single AMPs and streptomycin, with no significant fitness cost.
• Selection with a combination of AMPs resulted in bacterial extinction, mirroring the effect of vancomycin.
• Vancomycin also led to bacterial extinction, indicating a high efficacy against Staphylococcus aureus.

Conclusions:

• Simultaneous application of multiple AMPs can effectively prevent pathogen resistance evolution.
• This finding supports the hypothesis that endogenous AMP release during infection constrains the evolution of resistant strains.
• AMP combinations represent a viable strategy to overcome or prevent antimicrobial resistance.